176 related articles for article (PubMed ID: 23071580)
1. Zoledronate attenuates angiogenic effects of angiotensin II-stimulated endothelial progenitor cells via RhoA and MAPK signaling.
Yang JX; Chen B; Pan YY; Han J; Chen F; Hu SJ
PLoS One; 2012; 7(10):e46511. PubMed ID: 23071580
[TBL] [Abstract][Full Text] [Related]
2. The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ.
Yang JX; Pan YY; Chen B; Qiu YG; Mao W; Hu SJ
Cell Physiol Biochem; 2018; 47(6):2498-2510. PubMed ID: 29991018
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation.
Yamada J; Tsuno NH; Kitayama J; Tsuchiya T; Yoneyama S; Asakage M; Okaji Y; Shuno Y; Nishikawa T; Tanaka J; Takahashi K; Nagawa H
J Surg Res; 2009 Jan; 151(1):115-20. PubMed ID: 18619615
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells.
Imanishi T; Hano T; Nishio I
Hypertens Res; 2004 Feb; 27(2):101-8. PubMed ID: 15005273
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
6. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
Hasmim M; Bieler G; Rüegg C
J Thromb Haemost; 2007 Jan; 5(1):166-73. PubMed ID: 17059425
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
8. The effect of endothelial progenitor cells on angiotensin II-induced proliferation of cultured rat vascular smooth muscle cells.
Fang L; Chen MF; Xiao ZL; Yu GL; Chen XB; Xie XM
J Cardiovasc Pharmacol; 2011 Dec; 58(6):617-25. PubMed ID: 22146405
[TBL] [Abstract][Full Text] [Related]
9. Zoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cells.
Tsai SH; Huang PH; Chang WC; Tsai HY; Lin CP; Leu HB; Wu TC; Chen JW; Lin SJ
PLoS One; 2012; 7(7):e41065. PubMed ID: 22848429
[TBL] [Abstract][Full Text] [Related]
10. Actin stabilization by jasplakinolide affects the function of bone marrow-derived late endothelial progenitor cells.
Zhang X; Cui X; Cheng L; Guan X; Li H; Li X; Cheng M
PLoS One; 2012; 7(11):e50899. PubMed ID: 23226422
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
[TBL] [Abstract][Full Text] [Related]
12. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells.
Imanishi T; Hano T; Nishio I
Hypertens Res; 2005 Mar; 28(3):263-71. PubMed ID: 16097371
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
Endtmann C; Ebrahimian T; Czech T; Arfa O; Laufs U; Fritz M; Wassmann K; Werner N; Petoumenos V; Nickenig G; Wassmann S
Hypertension; 2011 Sep; 58(3):394-403. PubMed ID: 21825227
[TBL] [Abstract][Full Text] [Related]
14. Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro.
Xu XP; He HL; Hu SL; Han JB; Huang LL; Xu JY; Xie JF; Liu AR; Yang Y; Qiu HB
Stem Cell Res Ther; 2017 Jul; 8(1):164. PubMed ID: 28697804
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
[TBL] [Abstract][Full Text] [Related]
17. Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway.
Zhao Z; Ma X; Ma J; Sun X; Li F; Lv J
Chem Biol Interact; 2018 Apr; 286():45-51. PubMed ID: 29510123
[TBL] [Abstract][Full Text] [Related]
18. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.
Gao L; Li P; Zhang J; Hagiwara M; Shen B; Bledsoe G; Chang E; Chao L; Chao J
J Am Heart Assoc; 2014 Sep; 3(5):e001194. PubMed ID: 25237049
[TBL] [Abstract][Full Text] [Related]
19. Ang II induces capillary formation from endothelial cells via the AT1R-dependent inositol requiring enzyme 1 pathway.
Wang X; Bai YP; Hong D; Gao HC; Li LF; Li CC; Zhu LP; Sun Q; Zhang GG
Biochem Biophys Res Commun; 2013 May; 434(3):552-8. PubMed ID: 23583400
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Tada Y; Sekine I; Takiguchi Y; Tatsumi K; Kobayashi H; Shimada H; Hiroshima K; Tagawa M
Cell Death Dis; 2014 Nov; 5(11):e1517. PubMed ID: 25393473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
